Jeff Sperling

FAQ About Jeff Sperling

• What is Jeff Sperling's address?

  Jeff Sperling is located at
  Dallas, Texas, United States

• What is Jeff Sperling's job title?

  Jeff Sperling is a
  Attract. Attach. Activate. The precise way to build bone. Only i-FACTOR bone graft utilizes P-15 cell binding peptide to attract osteogenic cells to the fusion site, where they attach and activate molecular processes that build bone without the documented risks and costs of BMP-2.1,2,3,4 • P-15 peptide acts directly at the fusion site and nowhere else1,2,3,4 • 97.3% fusion rate at 24 months5,6 • Statistical superiority vs. autograft in overall clinical success5,6 • Backed by Level 1 human clinical data published in Spine and Neurosurgery5,6 1. Hennessy KM, Pollot BE, Clem WC, Phipps MC, Sawyer AA, Culpepper BK, Bellis SL. The effect of collagen 1 mimetic peptides on mesenchymal stem cells adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials. 2009 Apr; 30(10): 1898-909. 2. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun. 2003 Nov 7;311(1):179-86. 3. Yang XB, Bhatnagar RS, Li S, Oreffo RO. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng. 2004 Jul-Aug;10(7-8):1148-59. 4. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res. 1996 Aug;31(4):545-54. 5. Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Smucker JD, Vaccaro AR, Heary RF, Patel AL, Goulet B, Kalfas IH, Kopjar B. Efficacy of i-Factor Bone Graft versus Autograft in Anterior Cervical Disectomy and Fusion. Results of the Prospective Randomized Single-blinded Food and Drug Administration Investigational Device Exemption Study. Spine. 2016; 41(13): 1075-1083. 6. Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Heary RF, Vaccaro AR, Kopjar B. i-FACTOR Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study. (2018) Neurosurgery; Vol-83(3): pages 377-384. Astura Medical

• What industry does Jeff Sperling currently work in?

  Jeff Sperling currently works in the
  Astura Medical

• What is Jeff Sperling's area of expertise?

  Jeff Sperling specializes in
  Attract. Attach. Activate. The precise way to build bone. Only i-FACTOR bone graft utilizes P-15 cell binding peptide to attract osteogenic cells to the fusion site, where they attach and activate molecular processes that build bone without the documented risks and costs of BMP-2.1,2,3,4 • P-15 peptide acts directly at the fusion site and nowhere else1,2,3,4 • 97.3% fusion rate at 24 months5,6 • Statistical superiority vs. autograft in overall clinical success5,6 • Backed by Level 1 human clinical data published in Spine and Neurosurgery5,6 1. Hennessy KM, Pollot BE, Clem WC, Phipps MC, Sawyer AA, Culpepper BK, Bellis SL. The effect of collagen 1 mimetic peptides on mesenchymal stem cells adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials. 2009 Apr; 30(10): 1898-909. 2. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun. 2003 Nov 7;311(1):179-86. 3. Yang XB, Bhatnagar RS, Li S, Oreffo RO. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng. 2004 Jul-Aug;10(7-8):1148-59. 4. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res. 1996 Aug;31(4):545-54. 5. Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Smucker JD, Vaccaro AR, Heary RF, Patel AL, Goulet B, Kalfas IH, Kopjar B. Efficacy of i-Factor Bone Graft versus Autograft in Anterior Cervical Disectomy and Fusion. Results of the Prospective Randomized Single-blinded Food and Drug Administration Investigational Device Exemption Study. Spine. 2016; 41(13): 1075-1083. 6. Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Heary RF, Vaccaro AR, Kopjar B. i-FACTOR Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study. (2018) Neurosurgery; Vol-83(3): pages 377-384.

• Which languages does Jeff Sperling speak? 

  Jeff Sperling speaks the following languages:
  No languages available.

• Which industries has Jeff Sperling previously worked in?   

  Jeff Sperling has prior experience in the following industries:
  Depuy Synthes , Cerapedics , Globus Medical , Pacific Surgical Spine , Synthes , Medtronic Spine And Biologics

• What is Jeff Sperling’s work experience?  

  Jeff Sperling has the following professional experience:
  Astura Medical , Depuy Synthes , Cerapedics , Globus Medical , Pacific Surgical Spine , Synthes , Medtronic Spine And Biologics .

• How can I find Jeff Sperling on LinkedIn?  

  You can view Jeff Sperling’s
  LinkedIn profile at LinkedIn URL.

• What are Jeff Sperling’s work email addresses?  

  Jeff Sperling’s work email addresses are
  [email protected] .

• What company does Jeff Sperling work for?  

  Jeff Sperling works at
  Astura Medical